Comment on Colorado weather: Afternoon storms, heat advisories for Denver metro area

Open thread below read more

Tallahassee, Fla. — A 19-year-old and the club where she worked as a stripper have sued Florida’s attorney general and two local prosecutors to stop enforcement of a new state law prohibiting adult entertainment businesses from employing people who are under 21, claiming it violates their constitutional rights. Serenity Michelle Bushey claims in the lawsuit that she lost her job at Cafe Risque in the Gainesville area after the law took effect on Monday since she is younger than 21.

Santiago, Chile — Hannah, a 13-year-old white rhinoceros, has delivered a newborn calf in a rare zoo birth for the almost endangered species. The arrival of the male calf, named Silverio, two weeks ago marked the third time that a white rhino had ever been born in South America. The Buin Zoo in Chile’s capital of Santiago unveiled Silverio to the public on Tuesday as he took his first giant-footed steps after 12 days of medical care in confinement. [time-brightcove not-tgx=”true”] The zoo hailed his birth as a “big achievement” for conservationists worldwide.

Federal health officials are investigating a possible death and dozens of illnesses tied to recalled “microdosing” candies laced with a chemical found in mushrooms and sold online and in vape shops nationwide. At least 48 people in 24 states said they got sick after eating Diamond Shruumz-brand products, including chocolate bars, cones and gummies, the U.

Detroit — U. S. new-vehicle sales rose only slightly in the second quarter, despite larger discounts and slightly lower prices. But brisker sales could be on the horizon: Auto industry analysts say they expect prices to drop further and there’s a possibility of interest-rate cuts that would make taking out a loan for a new vehicle more affordable. [time-brightcove not-tgx=”true”] Overall, U.

On July 2, the U. S. Food and Drug Administration (FDA) approved a new drug for treating Alzheimer’s disease. Donanemab, or Kisunla, is the third drug approved to target one of the causes of Alzheimer’s: the buildup of amyloid protein in the brain. Based on the data provided by the drug’s manufacturer, Eli Lilly, for the FDA to review, it’s the most effective drug yet in slowing cognitive decline associated with the disease. [time-brightcove not-tgx=”true”] Studies reviewed by the FDA showed that the drug slowed progression to the next more-advanced stage of the disease by 39%, which translates to anywhere from four to seven months longer during which people can be more independent and function without extensive support from caregivers.